Quarterly report [Sections 13 or 15(d)]

Net Income (Loss) Per Share - Schedule of Outstanding Shares of Potentially Dilutive Securities (Details)

v3.26.1
Net Income (Loss) Per Share - Schedule of Outstanding Shares of Potentially Dilutive Securities (Details) - shares
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 18,796,272 10,220,673
Options to purchase common stock [Member]    
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 2,033,114 1,364,579
Warrants to purchase common stock [Member]    
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 478,419 478,419
Restricted Stock Units [Member]    
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 3,677 2,177
Common stock issuable upon conversion of Series B-2 convertible preferred stock [Member]    
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 300,000
Common stock issuable upon conversion of Series A-2 Prime convertible preferred stock [Member]    
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 462,245 1,115,145
Warrants to purchase convertible preferred stock [Member]    
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]    
Antidilutive Securities 15,818,817 6,960,353